Development of therapeutic approaches to ‘triple negative’ phenotype breast cancer

Author： Shiu Kai-Keen Tan David SP Reis-Filho Jorge S

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.9, 2008-09, pp. : 1123-1137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Approaches to Triple-Negative Breast Cancer: Current Practice and Future Directions

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 605-612

Bentham Science Publishers

Access to resources Recommend Favorite

Doxorubicin-Loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment

Current Drug Delivery, Vol. 15, Iss. 3, 2018-03 ,pp. : 406-416

Bentham Science Publishers

Access to resources Recommend Favorite

Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 70-80

Bentham Science Publishers

Access to resources Recommend Favorite

Triple-Negative Breast Cancer: Epidemiology and Management Options

By Dawood Shaheenah

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2247-2258

Adis International

Access to resources Recommend Favorite

Subtyping of triple-negative breast cancer: Implications for therapy

By Abramson Vandana G. Lehmann Brian D. Ballinger Tarah J. Pietenpol Jennifer A.

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 8-16

Blackwell Publishing

Access to resources Recommend Favorite